0001209191-18-024725.txt : 20180412 0001209191-18-024725.hdr.sgml : 20180412 20180412160520 ACCESSION NUMBER: 0001209191-18-024725 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180412 DATE AS OF CHANGE: 20180412 EFFECTIVENESS DATE: 20180412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ORAGENICS INC CENTRAL INDEX KEY: 0001174940 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 593410522 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-310046 FILM NUMBER: 18752156 BUSINESS ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 BUSINESS PHONE: 8132867900 MAIL ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 D 1 primary_doc.xml X0708 D LIVE 0001174940 ORAGENICS INC 4902 Eisenhower Blvd. Suite 125 Tampa FL FLORIDA 33634 813-286-7900 FLORIDA Oragen, Inc. None Corporation true Alan Joslyn 4902 Eisenhower Blvd. Suite 125 Tampa FL FLORIDA 33634 Executive Officer Director Michael Sullivan 4902 Eisenhower Blvd. Suite 125 Tampa FL FLORIDA 33634 Executive Officer Frederick Telling 4902 Eisenhower Blvd. Suite 125 Tampa FL FLORIDA 33634 Director Charles Pope 4902 Eisenhower Blvd. Suite 125 Tampa FL FLORIDA 33634 Director Robert Koski 4902 Eisenhower Blvd. Suite 125 Tampa FL FLORIDA 33634 Director Alan Dunton 4902 Eisenhower Blvd. Suite 125 Tampa FL FLORIDA 33634 Director Biotechnology No Revenues 06b false 2018-04-10 false true true true false 0 LADENBURG THALMANN & CO. INC. 505 None None 4400 Biscayne Boulevard Miami FL FLORIDA 33137 NJ NEW JERSEY NY NEW YORK 1800000 1800000 0 The total offering amount includes the concurrent registered offering of common stock. false 2 144000 0 Sales commissions relates to commissions for the sale of common stock in the concurrent registered offering. 0 false ORAGENICS INC /s/Michael Sullivan Michael Sullivan Chief Financial Officer 2018-04-12